These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 31311722)

  • 21. Interfraction variations in doses at OARs during three-dimensional high dose rate brachytherapy planning of cervix cancer.
    Dhaka S; Rajani A; Kumar HS; Sharma N; Jakhar SL; Harsh K
    J Cancer Res Ther; 2023; 19(5):1136-1141. PubMed ID: 37787275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of offline adaptive planning techniques in image-guided brachytherapy of cervical cancer.
    Liu H; Kinard J; Maurer J; Shang Q; Vanderstraeten C; Hayes L; Sintay B; Wiant D
    J Appl Clin Med Phys; 2018 Nov; 19(6):316-322. PubMed ID: 30284370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implications of applicators orientations on bladder, and rectal doses in gynecological mHDR brachytherapy: A retrospective analysis of reproducibility in multi-fractionated regimen.
    Srivastava AK; Rastogi M; Mishra SP
    J Cancer Res Ther; 2019; 15(6):1345-1351. PubMed ID: 31898671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy.
    Liu ZS; Guo J; Zhao YZ; Lin X; Zhang BY; Zhang C; Wang HY; Yu L; Ren XJ; Wang TJ
    Int J Gynecol Cancer; 2017 May; 27(4):768-775. PubMed ID: 28267131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicentre treatment planning study of MRI-guided brachytherapy for cervical cancer: comparison between tandem-ovoid applicator users.
    Nomden CN; de Leeuw AA; Van Limbergen E; de Brabandere M; Nulens A; Nout RA; Laman M; Ketelaars M; Lutgens L; Reniers B; Jürgenliemk-Schulz IM
    Radiother Oncol; 2013 Apr; 107(1):82-7. PubMed ID: 23127774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Automated applicator digitization for high-dose-rate cervix brachytherapy using image thresholding and density-based clustering.
    Deufel CL; Tian S; Yan BB; Vaishnav BD; Haddock MG; Petersen IA
    Brachytherapy; 2020; 19(1):111-118. PubMed ID: 31594729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reporting small bowel dose in cervix cancer high-dose-rate brachytherapy.
    Liao Y; Dandekar V; Chu JC; Turian J; Bernard D; Kiel K
    Med Dosim; 2016; 41(1):28-33. PubMed ID: 26235549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implications of bladder volume on target coverage and dose to critical structures during high dose rate intracavitary brachytherapy for cervical cancer: A dosimetric study.
    Patel RB; Gururajachar JM; Revathy T
    J Cancer Res Ther; 2019; 15(6):1207-1211. PubMed ID: 31898648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical impact of computed tomography-based image-guided brachytherapy for cervix cancer using the tandem-ring applicator - the Addenbrooke's experience.
    Tan LT; Coles CE; Hart C; Tait E
    Clin Oncol (R Coll Radiol); 2009 Apr; 21(3):175-82. PubMed ID: 19101130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer.
    Pelloski CE; Palmer M; Chronowski GM; Jhingran A; Horton J; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):131-7. PubMed ID: 15850913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer.
    Nomden CN; de Leeuw AA; Moerland MA; Roesink JM; Tersteeg RJ; Jürgenliemk-Schulz IM
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1424-30. PubMed ID: 21669505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in high-dose-rate tandem and ovoid applicator positions during treatment in an unfixed brachytherapy system.
    Pham HT; Chen Y; Rouby E; Lustig RA; Wallner PE
    Radiology; 1998 Feb; 206(2):525-31. PubMed ID: 9457208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective comparison of rectal dose reduction during intracavitary brachytherapy for cervical cancer using three rectal retraction techniques.
    Kong I; Vorunganti S; Patel M; Farrell T; Timotin E; Quinlan-Davidson S; Pond G; Sur R; Hunter R
    Brachytherapy; 2016; 15(4):450-455. PubMed ID: 27090224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Image-based 3D treatment planning for vaginal cylinder brachytherapy: dosimetric effects of bladder filling on organs at risk.
    Hung J; Shen S; De Los Santos JF; Kim RY
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):980-5. PubMed ID: 22138458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can MRI-only replace MRI-CT planning with a titanium tandem and ovoid applicator?
    Harkenrider MM; Patel R; Surucu M; Chinsky B; Mysz ML; Wood A; Ryan K; Shea SM; Small W; Roeske JC
    Brachytherapy; 2018; 17(5):747-752. PubMed ID: 29945764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiation Dose in the Uterine Perforation by Tandem in 3-Dimensional Cervical Cancer Brachytherapy.
    Tsai YL; Yu PC; Nien HH; Sung SY; Kuan YH; Wu CJ
    Med Dosim; 2019 Winter; 44(4):e59-e63. PubMed ID: 30846216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy.
    Susko M; Craciunescu O; Meltsner S; Yang Y; Steffey B; Cai J; Chino J
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1099-105. PubMed ID: 26883564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of "optimized" treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer.
    Noyes WR; Peters NE; Thomadsen BR; Fowler JF; Buchler DA; Stitt JA; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):79-86. PubMed ID: 7995771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of maximum rectal distention and tandem angle on rectal dose delivered in 3D planned gynecologic high dose-rate brachytherapy.
    Lim J; Durbin-Johnson B; Valicenti R; Mathai M; Stern RL; Mayadev J;
    Int J Gynecol Cancer; 2013 Jul; 23(6):1078-83. PubMed ID: 23792603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosimetric considerations when utilizing Venezia, Capri, Rotte double tandem, and tandem and ring with interstitial needles for the treatment of gynecological cancers with high dose rate brachytherapy.
    Schnell E; Thompson S; Ahmad S; Herman TS; De La Fuente Herman T
    Med Dosim; 2020 Spring; 45(1):21-27. PubMed ID: 31101569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.